The DOI matches its Crossref record.
Mature human eosinophils have the capacity to express HLA-DR.
Open accessAbstract
Human eosinophils are known to lose Ia antigen expression as they mature, and, accordingly, eosinophils obtained from the blood of five eosinophilic donors and three of four normal donors failed to display the major histocompatibility complex class II antigen HLA-DR, as determined by flow cytometry. However, when eosinophils from these nine donors were maintained in culture with recombinant human granulocyte-macrophage colony-stimulating factor and murine 3T3 fibroblasts, HLA-DR consistently developed on the eosinophils. By days 4-6 of culture, 24-97% of eosinophils were HLA-DR+, and the eosinophils remained morphologically mature. In contrast, another class II antigen, HLA-DQ, was not detectable by flow cytometry on eosinophils from eight of nine donors. Cultured eosinophils were able to synthesize HLA-DR, as documented by the incorporation of [35S]methionine into immunoprecipitable HLA-DR heavy and light chains. These findings show that mature eosinophils can synthesize and express HLA-DR and provide a means whereby eosinophils may interact with CD4+ lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Eosinophilic gastrointestinal disorders (EGID)
Rothenberg, M. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.047 · Cited by 923
Eosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Self-citationThe Immunobiology of Eosinophils
Flier, J. S., Underhill, L. H., & Weller, P. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241607 · Cited by 635
Self-citationThe many paths to asthma: phenotype shaped by innate and adaptive immunity
Kim, H. Y., DeKruyff, R. H., & Umetsu, D. T. (2010) · Nature Immunology · doi:10.1038/ni.1892 · Cited by 588
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Simons, J. W., Jaffee, E. M., Weber, C. E., Levitsky, H. J., Nelson, W. G., Carducci, M. A., Lazenby, A. J., Cohen, L. K., Finn, C. C., Clift, S. M., et al. (1998) · The Journal of Urology · doi:10.1097/00005392-199802001-00032 · Cited by 410
Pharmacology of the Eosinophil
Giembycz, M. A., & Lindsay, M. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01404-2 · Cited by 351
Eosinophils: multifaceted biological properties and roles in health and disease
Kita, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01026.x · Cited by 336
Lymph node trafficking and antigen presentation by endobronchial eosinophils
Shi, H.-Z., Humbles, A., Gerard, C., Jin, Z., & Weller, P. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8945 · Cited by 326
Self-citationEosinophils in innate immunity: an evolving story
Shamri, R., Xenakis, J. J., & Spencer, L. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1049-6 · Cited by 256
Eosinophils in Autoimmune Diseases
Diny, N. L., Rose, N. R., & Čiháková, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00484 · Cited by 172
Involvement of eosinophils in the anti-tumor response
Gatault, S., Legrand, F., Delbeke, M., Loiseau, S., & Capron, M. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1288-3 · Cited by 132
Metadata
- Authors
- Lucey, D. R., Nicholson-Weller, A., & Weller, P. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-02
- Volume
- 86
- Issue
- 4
- Pages
- 1348-1351
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1990075382
- Cited by
- 163
- References
- 0
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.